Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185951
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185957
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185961
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185964
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-10-20 2023-11-06 207683
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207686
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207689
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-SOTALOL 80MG TABLET Resolved 2023-01-06 2023-02-16 180086
APO-SOTALOL 160MG TABLET Resolved 2023-01-06 2023-02-16 180093
APO-SOTALOL 160MG TABLET Resolved 2023-03-09 2023-06-29 186569
APO-SOTALOL 80MG TABLET Resolved 2023-04-14 2023-06-29 189635
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-09-07 2018-09-15 60435
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-02-28 40835
APO FUROSEMIDE TAB 20MG 20MG TABLET Discontinued 2018-09-07 2018-09-15 60506
APO FUROSEMIDE TAB 40MG 40MG TABLET Discontinued 2018-09-07 2018-09-15 60509
APO FUROSEMIDE TAB 80MG 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO GLYBURIDE TAB 2.5MG 2.5MG TABLET Discontinued 2018-09-07 2019-07-04 60515
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO HYDRO TAB 100MG Discontinued 2019-11-26 2019-11-26 99653
APO HYDRO TAB 50MG 50MG TABLET Discontinued 2018-09-07 2019-02-13 60521
APO IBUPROFEN TAB 300MG 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO IBUPROFEN TAB 300MG 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793
APO IBUPROFEN TAB 400MG 400MG TABLET Discontinued 2019-01-02 2019-01-02 70799
APO IBUPROFEN TAB 400MG 400MG TABLET Discontinued 2018-09-07 2018-09-15 60530
APO METOPROLOL (TYPE L) TAB 50MG 50MG TABLET Discontinued 2018-09-07 2019-02-02 60634
APO METOPROLOL TAB 50MG 50MG TABLET Discontinued 2018-09-07 2019-01-09 60631
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO NAPROXEN TAB 250MG 250MG TABLET Discontinued 2017-03-30 2018-02-05 4734
APO OXAZEPAM TAB 10MG 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO OXAZEPAM TAB 15MG 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO OXAZEPAM TAB 30MG 30MG TABLET Discontinued 2018-09-08 2019-06-12 60681

Showing 21 to 40 of 365